NHS Dudley Health Economy Medicines Formulary
Home > 9 Nutrition and blood > 9.1 Anaemias and some other blood disorders > 9.1.4 Drugs used in platelet disorders > Thrombocytopenic purpura - eltrombopag - NICE TAG TA205

Thrombocytopenic purpura - eltrombopag - NICE TAG TA205

1.1 Eltrombopag is not recommended within its marketing authorisation for the treatment of chronic immune (idiopathic) thrombocytopenic purpura:

  • in splenectomised adults whose condition is refractory to other treatments (for example, corticosteroids, immunoglobulins) or

  • as second-line treatment in non-splenectomised adults where surgery is contraindicated.

1.2 People currently receiving eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura should have the option to continue treatment until they and their clinician consider it appropriate to stop.

 https://www.nice.org.uk/guidance/TA205

 

Site by Devopa
© Copyright 2020 NHS. All rights reserved.